Organisation paid for research Program year 2020 Source: CMS Open Payments

Acrc Studies ML Hakim Enterprises Inc

Neither a doctor nor a teaching hospital

Research payments

$28,205

8 payments

Through program year 2020, Acrc Studies ML Hakim Enterprises Inc is reported as receiving $28,205 in research payments, across 8 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$4,738	2
2019	Research	$23,467	6

Breakdown

Who paid Research payments · program years 2019–2020

Allergan Inc. $28,205 8 payments

Studies the money was for Research payments · program years 2019–2020

A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-Controlled, Operationally Seamless Phase 2b3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab in Participants with moderately to Severely Active Croh $13,205 2 payments
A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double- Dummy, Placebo and Active-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active Ulcerative Colitis $13,002 5 payments
A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-Controlled, Operationally Seamless Phase 2b/3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab in Participants with moderately to Severely Active Croh $1,998 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.